Monday, July 9, 2012

Some Birth Control Medications Can Increase A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death by Birth Control Blood Clot Death Lawyer

The Multi-Billion Dollar Birth Control Market Includes Several Drug Companies That Are Aggressively Birth Control That Increased A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death: Women on These Danagerous Birth Control Medications Should be Adequately Warned of the Health Risk by Texas Birth Control Heart Attack Lawyer and Blood Clot Death Lawyer Jason S. Coomer

As the $880 Billion per year global pharmaceutical market continues to expand, many drug companies are looking to make huge profits by selling contraceptives in the rapidly growing multi-billion birth control market.  Many of these drug companies are aggressively marketing contraceptives that increase a woman's risk of suffering a heart attack death, blood clot death, or debilitating stroke.

NuvaRing Is a Once A Month Birth Control That Has Been Linked To An Increased Risk That The Woman Using The Contraceptive Will Suffer a Heart Attack Death, Blood Clot Death, or Debilitating Stroke by Texas NuvaRing Heart Attack and Blood Clot Death Lawyer Jason S. Coomer

The contraceptive, NuvaRing, is a once a month birth control device that has been scientifically linked to an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.  Several NuvaRing Heart Attack Death and Blood Clot Death Lawyers have filed and are currently filing NuvaRing Lawsuits alleging that Merck, the maker of NuvaRing failed to adequately warn women and their doctors about the risks associated with the NuvaRing device.  For more information on NuvaRing Lawsuits, Texas NuvaRing Lawsuits, and International NuvaRing Lawsuits, please  please feel free to contact Texas NuvaRing Heart Attack Death Lawyer and NuvaRing Blood Clot Death Lawyer Jason Coomer or go to the following web page: NuvaRing Heart Attack Death Lawsuit, NuvaRing Blood Clot Death Lawsuit, and NuvaRing Stroke Lawsuit Information.


The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer
Other hormonal contraceptives including YAZ, Ocella, Beyaz, and Yasmin are also the subject of lawsuits alleging that Bayer HealthCare Pharmaceuticals, Inc. has run false marketing campaigns that were misleading regarding the potential health risks that have been associated with these oral contraceptives.  These lawsuits are also alleging that these drugs cause an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.    
For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive lawsuits, please feel free to  contact Texas Birth Control Heart Attack, Stroke, and Blood Clot Death Lawyer Jason S. Coomer or go to the following web page: YAZ Heart Attack Death Lawsuit, YAZ Blood Clot Death Lawsuit, and YAZ Stroke Lawsuit Information.

Sunday, July 8, 2012

Fatal Blood Clots Can Be Caused By Defective Drugs and Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal Blood Clots Can Be Caused By Defective Drugs and Defective Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal blood clots are on the rise as drug companies and medical device manufacturers have aggressively marketed drugs and medical devices that can cause an increased risk of blood clots resulting in heart attacks, strokes, and pulmonary embolisms.  Person using hormonal contraceptives and medical devices that increase their risk of a fatal blood clot should be aware of the potential danger and warning signs of a blood clot.  If you have lost someone from a fatal blood clot or have experienced a serious injury from a blood clot related to a defective drug or medical device, it is important to make sure the adverse event is reported to the prescribing doctor and FDA.

The Birth Control Contraceptive, NuvaRing, Has Been Linked To An Increased Health Risk of Fatal Blood Clots by Texas NuvaRing Blood Clot Lawyer Jason S. Coomer
The hormonal long lasting contraceptive, NuvaRing, is the subject of several lawsuits alleging that the once a month birth contraceptive may cause fatal blood clots and other serious health problems for women that are using this medical device.  For more information on NuvaRing Blood Clot Lawsuits, please go to the following web page: NuvaRing Fatal Blood Clot Lawsuits and NuvaRing Death Lawsuits.

The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer
YAZ, Ocella, Beyaz, and Yasmin are oral hormonal contraceptives have been aggressively marketed to young women despite research that indicates that the drugs may cause an increased risk of fatal blood clots. For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive  blood clot lawsuits, please go to the following web page: YAZ Blood Clot Lawsuits, Yasmin Blood Clot Lawsuits, Ocella Blood Clot Lawsuits, Beyaz Blood Clot Lawsuits and Birth Control Blood Clot Death Lawsuits.

Defective Inferior Vena Cava Filters Can Break Apart, Perforate, and Migrate in a Person's Body Causing Fatal Blood Clots and Embolisms by Texas IVC Filter Blood Clot Lawyer Jason S. Coomer
Defective Inferior Vena Cava Filters can migrate, fracture, and break apart inside a person causing fatal blood clots and embolisms.  The FDA recommends that persons with inferior vena cava filters (IVC filters) should contact their doctors regarding removal of the devices.  For more information on IVC Filter Blood Clot Lawsuits, please feel free to go to the following web page: Texas IVC Filter Blood Clot Lawyer and Inferior Vena Cava Filter Failure Embolism Lawyer,

Friday, July 6, 2012

Heart Doctors Concerned Over Pradaxa and Xarelto

 Evidence of the harm caused by the blood thinning drugs Pradaxa and Xarelto continues to grow.  How safe are these drugs and are they really preferable to Wafarin?  Doctors warn that neither of these new drugs has a known antidote for excessive bleeding issues, but Wafarin does.


http://www.huffingtonpost.com/2012/06/14/pradaxa-xarelto-blood-thinner-doctors-heart_n_1595971.html

 "They say that real world use of Pradaxa and Xarelto, which do not require regular blood monitoring or frequent doctor follow-up, raises concerns about the risk of stroke, serious bleeding and blood clots if not taken properly, particularly in patients with poor kidney function.

The nonprofit Institute for Safe Medication Practices estimated last month that 542 reports of deaths associated with Pradaxa were reported to the FDA in 2011, topping all other medicines, including warfarin, with 72 deaths. Adverse event reports on Xarelto were not available."

Tuesday, June 26, 2012

Hip Maker Discussed Failures

More details emerge surrounding Johnson and Johnson' Depuy hip replacement failures.  How aware was the company that their product was unsafe?

 http://www.nytimes.com/2012/02/22/business/flawed-depuy-hip-implant-had-early-fda-notice.html?pagewanted=all

"Throughout the episode, DePuy blamed orthopedic surgeons for the model’s failures, saying that doctors were not positioning a component properly. But the clinical findings rejected by the F.D.A. came from A.S.R. studies run by surgeons hand-picked by DePuy, including some who had developed the implant and received royalties or consulting fees in connection with it."

Wednesday, June 20, 2012

Popular diabetes drugs may raise pancreatic cancer risk, study suggests

 People with type 2 diabetes taking the drugs Januvia or Byetta might have an increased risk of developing pancreatitis and pancreatic cancer, a preliminary study suggests. 
The study also found that Byetta (exenatide) may raise the risk of thyroid cancer.
Although the links aren't conclusive, they merit further investigation, the researchers noted.
"We have raised concern that there may be a link, but we haven't confirmed it," said lead researcher Dr. Peter Butler, director of the Larry L. Hillblom Islet Research Center at the University of California, Los Angeles. "We need to do more work to figure out whether this is real or not."
Both drugs help control blood sugar levels by encouraging production of a hormone called glucagon-like peptide 1 (GLP-1).
Januvia (sitagliptin) and Byetta, an injectable drug, are a new way of treating type 2 diabetes, and they potentially have advantages over older medications, Butler said. But, because these drugs are new, they're "the ones we know least about," he said. "When new drugs come out, the long-term side effects of these drugs are not well understood."
For the study, recently published in the journal Gastroenterology, Butler's team used 2004-2009 information in the U.S. Food and Drug Administration's database on adverse events, which are reported by doctors whose patients use these drugs.
When compared to other treatments, the researchers found a sixfold increase of reported cases of pancreatitis (inflammation of the pancreas) linked to patients taking Januvia or Byetta; a 2.9-fold increase in reported cases of pancreatic cancer among those taking Byetta and a 2.7-fold increase of reported pancreatic cancers among Januvia users.
In addition, they also noted an increase in reported cases of thyroid cancer with Byetta.

 http://www.usatoday.com/news/health/medical/health/medical/story/2011-09-23/Popular-diabetes-drugs-may-raise-pancreatic-cancer-risk-study-suggests/50531776/1

Saturday, May 19, 2012

Several Birth Defects Including Neural Tube Defects, Cleft Palate Defects, Cleft Lip Defects, and Spina Bifida Defects Have Been Linked to The Use of Prescribed Antidepressants and Other Medications: Pregnant Women and Women that May Get Pregnant Should Be Aware of These Potential Health Risks by Neural Tube Birth Defect Lawyer, Cleft Palate Birth Defect Lawyer, Cleft Palate Birth Defect Lawyer, and Spina Bifida Birth Defect Lawyer Jason S. Coomer

Several Birth Defects Including Neural Tube Defects, Cleft Palate Defects, Cleft Lip Defects, Heart Defects, and Spina Bifida Defects Have Been Linked to The Use of Prescribed Antidepressants and Other Medications: Pregnant Women and Women that May Get Pregnant Should Be Aware of These Potential Health Risks by Neural Tube Birth Defect Lawyer, Cleft Palate Birth Defect Lawyer, Cleft Palate Birth Defect Lawyer, and Spina Bifida Birth Defect Lawyer Jason S. Coomer

Several medications, products, and drugs have been linked to birth defects including neural tube defects, cleft palate, cleft lips, and spina bifida.  Unfortunately, through strong marketing pressure some drug companies have been continuing to push doctors to prescribe drugs that may cause severe birth defects to pregnant women and women that may become pregnant for FDA approved uses and off-label usesThese birth defects can result in death or injury to an infant including malformation, permanent paralysis, disabilities, and severe health problems.

Selective Serotonin Reuptake Inhibitors (SSRIs) May Cause Neural Tube Birth Defects, Cleft Palate Birth Defects, Cleft Lip Birth Defects, Clubbed Foot Birth Defects, Heart Birth Defects,  and Spina Bifida Birth Defects by SSRI Neural Tube Birth Defect Lawyer, Primary Pulmonary Hypertension (PPHN) Lawyer, Prozac Birth Defect Lawyer, Zoloft Birth Defect Lawyer, Zoloft Birth Defect Lawyer and Paxil Birth Defect Lawyer Jason S. Coomer

A growing body of evidence indicates that several drugs and medications, if used during pregnancy may cause serious birth defects.  These drugs include selective serotonin-reuptake inhibitor SSRI antidepressants.  Selective serotonin reuptake inhibitors (SSRIs) are commonly used as antidepressants. Drugs included in the SSRI class are Prozac, Zoloft, Paxil, Symbyax, Celexa, Cymbalta, Effexor and Lexapro.

These SSRI antidepressants may cause birth defects and developmental problems if taken during pregnancy.  Some potential birth defects and developmental problems include neural tube birth defects, heart defects, cleft palates, cleft lips, clubbed feet, as well as other malformations and developmental problems.  These selective serotonin-reuptake inhibitor (SSRI) drugs have been strongly marketed by the drug companies and are commonly used to treat depression and other disorders.  Some of the most popular SSRI antidepressants are: Paxil (paroxetine hydrochloride), Prozac (fluoxetine), Zoloft (sertraline), Lexapro (escitalopram), Celexa (citalopram), and Effexor (venlafaxine).

The Anticonvulsant Drug Topamax May Cause an Increased Risk of Birth Defects Including Cleft Lip Birth Defects and Cleft Palate Birth Defects by Topamax Birth Defect Lawyer, Topiramate Birth Defect Lawyer, Topamax Heart Defect Lawyer, Topamax Cleft Palate Lawyer, Topamax Cleft Lip Lawyer, and Antiepileptic Drug (APD) Birth Defect Lawyer 

 
Topiramate (brand name Topamax) is a anticonvulsant drug. It has been approved for the treatment of epilepsy and migraines, but has been aggressively marketed for many off-label uses including bipolar disorder, cluster headaches, eating disorders, obesity, fibromyalgia, depression, posttraumatic stress disorder (PTSD), alcoholism, sleep disorders, sleep-eating disorders, infantile spasms, autism, periventricular leukomalacia in preterm infants after an hypoxic-ischemic injury, essential tremor, bulimia nervosa, obsessive-compulsive disorder, smoking cessation, idiopathic intracranial hypertension, neuropathic pain, and cocaine dependence.  If you or a loved one have been taking Topamax during pregnancy and had a child with a birth defect, it is important to seek medical assistance.

The FDA recommends that "before starting topiramate, pregnant women and women of childbearing potential should discuss other treatment options with their health care professional. Women taking topiramate should tell their health care professional immediately if they are planning to or become pregnant. Patients taking topiramate should not stop taking it unless told to do so by their health care professional. Women who become pregnant while taking topiramate should talk to their health care professional about registering with the North American Antiepileptic Drug Pregnancy Registry, a group that collects information about outcomes in infants born to women treated with antiepileptic drugs during pregnancy."
 
The FDA has recently announced that Topiramate (brand name Topamax) causes an increased risk of development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with Topamax (topiramate) during pregnancy. If you or a loved one have been taking Topamax during pregnancy and had a child with a birth defect, it is important to seek medical assistance. 


The Anticonvulsant Drug Depakote May Cause Birth Defects Including Spina Bifida and Neural Tube Defects by Depakote Birth Defect Lawyer, Depakote Spina Bifida Lawyer, Depakote Neural Tube Defect Lawyer, and Depakote Birth Defect Lawsuit Information

The drug, Depakote, aka Depakote ER, Depakene, Depacon, Epival, Dépakine Chrono,Valance, and divalproex sodium (USAN) is a drug prescribed to treat seizures, migraine headaches, manic episodes of bipolar disorder, major depressive disorder, prevention of both manic and depressive phases of bipolar disorder, epilepsy, chronic pain associated with neuropathy, and migraine headaches. Further, with the increase in pharmaceutical marketing off-label use of the drug has become more prevalent including treatment of mild depression, the depressive stage of bi-polar disorder, and chronic pain such as migraine headaches.

Depakote has been linked to major birth defects in children of women that were taking this drug.  According to a recent medical scientific study, women taking Depakote had four times the risk of delivering a child with major birth defects, compared to women taking other, similar drugs.  The range of birth defects associated with Depakote is broad, however the report specifically cited neural tube defects such as spina bifida. Neural tube defects are birth defects that affect the brain and spinal cord; spinal bifida is a defect affecting the spinal cord that causes paralysis of the legs. There is no known cure.

Women that take Depakote, Depakote ER, Depakene, Depacon, Dépakine Chrono, and other forms of divalproex sodium, while they are pregnant may be at higher risk to have children with serious birth defects including spina bifida, cleft palate, cleft lip, and malformations.  If you believe that you or someone in your family is on Depakote or Depakote ER while pregnant, please contact a doctor immediately. 

Adverse Reactions to Medications Including Birth Defects Need to Be Reported to Health Care Providers and the FDA by Texas Pharmaceutical Birth Defect Lawyer, Antidepressant Birth Defect Lawyer, and Birth Injury Lawyer Jason S. Coomer
 
Avoidable birth defects are one of the most devastating problems that can occur to a family and a new baby.  Parents who should be celebrating the birth of a new child, are often caught off guard when their child is born with severe disabilities and often  do not realize that someone may be responsible for the birth defect including drug manufacturers that hid information about medications that can cause birth defects.  The family is typically busy taking care of the child with the serious health problems and often does not know that the birth defect was preventable.  When they discover the probable cause of the preventable birth defect they are often filled with anger and rage.  It can be horrifying to find out that a child will have permanent health problems because a drug company hid research and did not provide an adequate warning of a product's safety. 


Several antidepressant drugs and other medications prescribed for off label and FDA approved uses have been linked to birth defects including neural tube defects, cleft palate, cleft lips, and spina bifida.  Unfortunately, some drug companies have been able to push doctors to prescribe drugs to pregnant women that may cause severe birth defects.  These birth defects can result in serious and permanent to a child including malformation, permanent paralysis, disabilities, and severe health problems.  It is important to communicate with your doctor to make sure that you both understand these potential health hazards.

If you have a child with a birth defect and have taken the above mentioned medications or another type of medication that may be the cause of a birth defect, it is important that the adverse health results be reported to provide information to both doctors and the FDA of adverse events that need to be prevented in the future.

Tuesday, May 15, 2012

The Diabetes Drug Actos May Cause An Increased Risk of Bladder Cancer That Can Metastasize into Lung Cancer, Lymphatic Cancer, Liver Cancer, Bone Cancer, Prostate Cancer, Rectum Cancer, or Vaginal Cancer by Texas Actos Bladder Cancer Lawyer, Texas Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

The Diabetes Drug Actos May Cause An Increased Risk of Bladder Cancer That Can Metastasize into Lung Cancer, Lymphatic Cancer, Liver Cancer, Bone Cancer, Prostate Cancer, Rectum Cancer, or Vaginal Cancer by Texas Actos Bladder Cancer Lawyer, Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

Actos is a diabetes drug that has been prescribed to more than 10 million Americans since its approval for the treatment of type 2 diabetes.  It is an extremely profitable drug in that it has had multi-billion dollar annual global sales and has created large profits for its manufacturer.  Actos is manufactured by Takeda Pharmaceutical Co.  However, Actos has been linked to an increased risk of bladder cancer and has been pulled off the market in some European countries.  Actos is now under review by the FDA to determine if it will be pulled from the market or additional black box warnings will be added to the drug. 

Actos May Cause An Increased Risk of Bladder Cancer

Bladder Cancer is a form of cancer that begins in the lining of the bladder as a superficial tumor.  Bladder cancer can spread and metastasize into the lungs, liver, or bones resulting in serious health issues and even death. If left untreated bladder cancer can metastasize into lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, and vaginal cancer. The most common symptom of bladder cancer is blood in the urine.  If you or a loved one have been taking Actos and have experienced blood in your urine, please contact your doctor immediately.  If you suffer from bladder cancer, lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, or vaginal cancer and were taking Actos, please report the adverse facts.  If you have lost a person that you love from a bladder cancer, lung cancer, lymphatic cancer, liver cancer, bone cancer, prostate cancer, rectum cancer, uterine cancer, or vaginal cancer and your loved one was taking Actos, please report the adverse facts.

  Bladder Cancer Can Be Treated If Caught Early: People That Have Taken Actos or Are Taking Actos Should Be Aware of the Warning Signs of Bladder Cancer and Communicate with Their Doctor To Make Sure that They Are Both Aware of Any Symptoms by Texas Actos Bladder Cancer Lawyer, Texas Diabetes Drug Cancer Lawyer, Diabetes Bladder Cancer Lawyer, and Texas Actos Cancer Death Lawyer

Most bladder cancers begin in the transitional cells as transitional cell carcinoma, but can spread into nearby organs.  When bladder cancer spreads beyond the bladder, the malignant cells are frequently found in nearby lymph nodes and may have spread to other lymph nodes or other places including the lungs, liver, or bones.  The most common warning sign is blood in the urine. If there is enough blood to color the urine it may range from slightly rusty to deep red. Other symptoms may be pain during urination and frequent urination or feeling the need to urinate without results. 

Bladder cancer can be diagnosed into several different stages.  Stage 0 Bladder Cancer patients have noninvasive tumors that are only in the bladder lining; Stage I Bladder Cancer Patients have tumor(s) through the bladder lining, but the tumor(s) do not reach the muscle layer of the bladder; Stage II Cancer Patients have tumor(s) that go into the muscle layer of the bladder; Stage III Cancer Patients have tumor(s) that go past the muscle layer into tissue surrounding the bladder; and Stage IV Bladder Cancer Patients have tumor(s) that have spread to neighboring lymph nodes or to distant sites (metastatic disease) including the lungs, liver, bones, prostate, stomach, rectum, ureters, uterus,  and vagina.

Primary malignant bladder cancer can be classified by health care providers in several different categories depending on where it is found including the dome of urinary bladder; lateral wall of urinary bladder; anterior wall of urinary bladder; posterior wall of urinary bladder; bladder neck; ureteric orifice; urachus; and malignant neoplasm of contiguous or overlapping sites of bladder whose point of origin cannot be determined.

Carcinoma in situ is cancer that remains confined to the bladder lining. Bladder cancer may grow into or through the bladder wall and eventually into lymph nodes, lungs, liver, bones, or other nearby areas.